This issue, IBO has made two changes to its Lab Equipment/Consumables Sales Index. Merck KGaA was removed from the Index, while Thermo Fisher Scientific’s Laboratory Products and Services segment was added. Fourth quarter sales for the new Lab Equipment/Consumables Index gained 11.9% to $769 million, while operating profits improved 15.5% to $200 million. Operating margin […]
The South Korean government designated KRW 9.7 trillion ($10.4 billion) for R&D programs this year, an increase of 9.6% from last year. Since 2003, R&D spending has increased an average of 10.6% each year. The government established a science and technology innovation headquarters two years ago, which monitors and seeks to improve the efficiency of […]
Automated liquid handling (ALH) is instrumental in drug discovery initiatives and has helped speed the workflow in life science research laboratories. Although growth in the ALH market is not what it used to be, the market continues to provide innovative advancements such as low-volume dispensing systems for key applications in drug discovery. There are several […]
Dr. Karen A. Holbrook, president of Ohio State University, joined Techne’s board in February. In February, BD Biosciences and Roche announced a collaboration to jointly identify and develop intracellular phosphorylation site antibodies. The companies will develop and validate the antibodies using BD Phosflow technology, and Roche will receive pre-launch access to the antibodies and a […]
Under a strategic alliance announced in February, VWR International’s BioSciences program will offer Tecan’s microarray instruments and microplate readers.
SII NanoTechnology introduced the L-trace II large-stage unit SPM, featuring a new accurate scanner and a standard closed loop scanner, and the S Image multifunction-unit SPM, featuring a new low-coherence optical head. FEI launched the Quanta 3D FEG SEM/FIB (Focused Ion Beam) Dual Beam, featuring three operating modes, for advanced three-dimensional nanoscale characterization, prototyping and […]
In January, AMETEK formed the Ultra Precision Technologies Division to bring together its Taylor Hobson division with Solartron Metrology and Precitech in order to leverage combined manufacturing operations, technology capabilities and distribution. Symyx Technologies’ 2006 revenues grew 16% to $124.9 million (see page 12), including a 23% increase in Symyx Tools revenues to $37.8 million […]
In December 2006, SYSTAG AG, a provider of automated solutions for chemical process development, announced a management buyout of a majority share of the company. Tecan appointed Matthew Robin and Carl Severinghaus to its Group Executive Committee. Mr. Robin is responsible for the Liquid Handling and Robotics business unit. He was previously CEO of medical […]
The Pharmaceutical Research and Manufacturers of America’s (PhRMA) “2007 Pharmaceutical Industry Profile” reports that, in 2006, total sales for PhRMA member companies increased 4.2% to $245.8 billion. In 2006, PhRMA member companies spent an estimated $43.0 billion on R&D, a 7.8% increase. R&D as a percentage of sales among member companies in 2006 is estimated […]
Alpha Innotech’s 2006 revenues grew 10% to $13.3 million due to increased sales to international distributors and GE Healthcare, but were offset by declining US sales (see page 12). Revenues from outside the US accounted for 43.9% of sales.
Pay Invoice
Latest Blogs
-
Syncell: Advancing Spatial Proteomics
June 30, 2025 3:41 pm
-
SDi Forecasts Growth in Demand for Analytical Instruments 2024–2029
May 29, 2025 1:38 pm
-
NIH Disruptions and Lab Tool Companies: Stocks React
April 30, 2025 1:17 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
